Table 1.
Results of the concentrations of RSP and 9-HR in hair and in serum from 34 subjects
| Daily dosage (mg/day) |
Hair | Serum | |||||
| RSP (ng/mg) | 9-HR (ng/mg) | RSP+9-HR (ng/mg) | RSP (ng/mL) | 9-HR (ng/mL) | RSP+9-HR (ng/mL) | ||
| Male (n=13) | 4.0 (2.0–4.0) | 13.1 (10.85–28.35) | 0.551 (0.3415–0.7598) | 13.469 (11.158–28.812) | 5.4 (2.9–15.9) | 14.7 (10.35–19.05) | 18.6 (16.4–33.1) |
| Female (n=21) | 4.5 (2.5–5.0) | 11.8 (3.50–19.05) | 0.223 (0.0675–1.2495) | 12.967 (4.106–19.153) | 7.3 (2.40–13.25) | 23.1 (14.5–38.1) | 30.6 (21.2–42.8) |
9-HR, 9-hydroxyrisperidone; RSP, risperidone.